(Q39733536)

14 September 2017

1 reference

title

Potential applications of therapeutic drug monitoring in treatment of neoplastic disease by antineoplastic agents (English)

1 reference

14 September 2017

1

Erlichman C

1 reference

14 September 2017

1 April 1986

1 reference

14 September 2017

Clinical Biochemistry

1 reference

14 September 2017

19

1 reference

14 September 2017

101-106

1 reference

14 September 2017

2

1 reference

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

The clinical pharmacology of methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

High-dose methotrexate: Preliminary evaluation of a pharmacokinetic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Drug dosage and remission duration in childhood lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: a selective and novel procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

7 January 2021

Oral melphalan kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

The anthracycline antineoplastic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Doxorubicin cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Clinical Pharmacokinetics of Cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

High-performance liquid chromatographic measurement of cyclophosphamide in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

The glucose distribution in 9L rat brain multicell tumor spheroids and its effect on cell necrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2886%2980055-8

10.1016/S0009-9120(86)80055-8

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3518986